Your browser doesn't support javascript.
loading
Daylight PDT with MAL - current data and practical recommendations of an expert panel.
Philipp-Dormston, Wolfgang G; Karrer, Sigrid; Petering, Holger; Ulrich, Claas; Dirschka, Thomas; Berking, Carola; Lonsdorf, Anke S; Gerber, Peter Arne; Radakovic, Sonja; Hunger, Robert E; Szeimies, Rolf-Markus.
Afiliação
  • Philipp-Dormston WG; Skin Center Cologne, Cologne, Germany.
  • Karrer S; Department of Dermatology, University Hospital Regensburg, Regensburg, Germany.
  • Petering H; Dermatology practice, Hildesheim, Germany.
  • Ulrich C; Skin Tumor Center of Charité, Berlin, Germany.
  • Dirschka T; Centroderm Hospital, Wuppertal and Witten-Herdecke University, Witten, Germany.
  • Berking C; Department of Dermatology and Allergology, Munich University Hospital (LMU), Munich, Germany.
  • Lonsdorf AS; Department of Dermatology, Ruprecht Karls University Heidelberg, Heidelberg, Germany.
  • Gerber PA; Department of Dermatology, University Hospital Düsseldorf, Düsseldorf, Germany.
  • Radakovic S; Department of Dermatology and Dermato-oncology, Division of General Dermatology, Vienna, Austria.
  • Hunger RE; Department of Dermatology, Inselspital Hospital, Bern University, Bern, Switzerland.
  • Szeimies RM; Department of Dermatology and Allergology, Vest Hospital, Teaching Hospital, Recklinghausen, Germany.
J Dtsch Dermatol Ges ; 13(12): 1240-9, 2015 Dec.
Article em En | MEDLINE | ID: mdl-26612792
ABSTRACT
Photodynamic Therapy (PDT) is one of the standard treatment modalities for actinic keratoses (AKs). Daylight PDT (DL-PDT) with MAL cream is a rather recent development, which, instead of an artificial light source, uses daylight for the activation of the photosensitizer. The present review summarizes available data based on a selective literature search, highlights practical aspects, and reflects the authors' expert knowledge in using DL-PDT. With respect to efficacy, study data shows that DL-PDT is noninferior to conventional PDT (cPDT). However, given that DL-PDT is markedly less painful, it is significantly better tolerated than cPDT. In Europe, DL-PDT can be performed from March to October, on sunny as well as on cloudy days. UV protection of untreated areas of the body should be observed. Outside temperature should not fall below 10°C. On hot days, patients should be advised to stay in the shade if necessary. Representing a useful addition to current therapeutic options, DL-PDT with MAL cream is, among others, suitable for patients with field cancerization and/or those who have experienced severe pain associated with cPDT.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Dor / Fotoquimioterapia / Guias de Prática Clínica como Assunto / Ceratose Actínica / Ácido Aminolevulínico Tipo de estudo: Etiology_studies / Guideline Limite: Humans País como assunto: Europa Idioma: En Ano de publicação: 2015 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Dor / Fotoquimioterapia / Guias de Prática Clínica como Assunto / Ceratose Actínica / Ácido Aminolevulínico Tipo de estudo: Etiology_studies / Guideline Limite: Humans País como assunto: Europa Idioma: En Ano de publicação: 2015 Tipo de documento: Article